Treatment of non-puerperal galactorrhoea with an ergot alkaloid.
Three patients suffering from non-puerperal galactorrhoea over periods ranging from two months to six years were treated with an ergot alkaloid, 2-Br-alpha-ergocryptine (CB 154). In all three cases the galactorrhoea was terminated. The apparent prolactin antagonism exhibited by this compound is discussed.
D000328:Adult; D004876:Ergot Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy* / Q000209:etiology; D010911:Pituitary Neoplasms / Q000150:complications; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors
D004876:Ergot Alkaloids; D011388:Prolactin